People are seen at the booth of Kangmei Pharmaceutical at a trade and service fair in Beijing on May 31, 2018. Photo: Reuters
Why is Kangmei Pharmaceutical, found to have committed one of China’s biggest financial frauds, rallying?
- Regulator imposes tiny fine, does not signal Kangmei Pharmaceutical will be delisted
- Shows light punishment gives companies ‘great motivation’ to cheat, analyst says
Topic |
China stock market
People are seen at the booth of Kangmei Pharmaceutical at a trade and service fair in Beijing on May 31, 2018. Photo: Reuters